Arkolith/Insider Trading/STRO/Form 4

Borgman Anne Elizabeth

CHIEF MEDICAL OFFICERSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed May 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)16K—$0122K
May 1, 2025Option exercise(M)53K—$0106K
May 1, 2025Tax withholding(F)25K$1.07$26K97K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)16K—$018K
May 1, 2025Option exercise(M)53K—$022K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-011996) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML